Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksManolete Partn. Regulatory News (MANO)

Share Price Information for Manolete Partn. (MANO)

Share Price is delayed by 15 minutes
Get Live Data
39.50    3.00 (8.00%)
Bid:
38.00
Ask:
41.00
Spread: 3.00 (7.895%)
Market Cap: £17.74m
MANO Live PriceLast checked at - London Stock Exchange

Intraday Manolete Partn. Share Chart

Directorate Changes

31 Mar 2026 07:00

RNS Number : 7008Y
Manolete Partners PLC
31 March 2026
 

31 March 2026

 

 

Manolete Partners PLC

("Manolete" or the "Company")

 

Directorate Changes

 

Manolete is delighted to announce the appointment of Marcia Shekerdemian KC to the Board as a Non-Executive Director with effect from 31 March 2026.

 

Marcia is a leading barrister in all aspects of contentious and non-contentious insolvency, company and partnership law as well as commercial litigation. She sat in the High Court as a Deputy Insolvency and Companies Court Judge from 2000 to 2025, and remains in private practice as a barrister as a member of Wilberforce Chambers. Marcia will join the Audit Committee and chair the Remuneration Committee.

 

She will replace Dr. Stephen Baister on the Board, who will step down as a Non-Executive Director with effect from the same date. Stephen will continue to provide consultancy to the Company.

 

Lord Leigh of Hurley, Chairman of Manolete said:

 

"I am delighted that Marcia has agreed to join the Board. She brings extensive knowledge across insolvency litigation and I look forward to working with her over the coming years.

 

"I would also like to thank Stephen for his work as a senior adviser to Manolete and then as a Non-Executive Director since 2018. His knowledge of insolvency law and critical thinking have been very important to the Board. I am pleased that he will continue to deliver the benefits of his deep expertise as a consultant to the Company."

 

Marcia Shekerdemian KC, commenting on her appointment as a Non-Executive Director of Manolete said:

 

"As the UK's leading insolvency claims financing company, Manolete is deservedly well-known and respected for the quality and efficacy of its work helping creditors increase returns on claims that otherwise wouldn't be pursued. The Company has a proven, unique business model and I am looking forward to supporting the Board to build on Manolete's growth to date."

 

 

The following information is disclosed pursuant to paragraph (g) of Schedule 2 to the AIM Rules:

 

Marcia Shekerdemian KC aged 62 is currently a director of Middle Temple Charity, and in the last 5 years has been a director of the Leonard Cheshire Disability Charity. There are no further items to be disclosed.

 

For further information please contact:

 

Manolete Partners

Mena Halton (Chief Executive Officer) via Houston

Will Sawyer (Chief Financial Officer)

 

Canaccord (NOMAD and Sole Broker) +44 (0)20 7523 8000

Stuart Andrews

Emma Gabriel

Harry Rees

 

Houston (Financial PR) +44 (0)77 3303 2695

Charlie Barker +44 (0)20 4529 0549

Nick Jackman

Manolete@houston.co.uk

 

About Manolete Partners PLC

Manolete Partners Plc is the UK's leading insolvency claims financing company. Serving a growing market worth over £500 million annually, the Company has a highly experienced team with coverage across the UK and a proven track record of generating strong historic returns across over 1,300 cases financed and completed to date.

 

Widely recognised as the industry leader, Manolete is the only company in the insolvency litigation funding section to be ranked in Band 1 of the legal industry's prestigious Chambers Guide five times. The Company is also five-time winner of 'Insolvency Litigation Funder of the Year' at the Turnaround, Restructuring and Insolvency Industry Awards.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABLGDXGXXDGLG
Date   Source Headline
31st May 20247:00 amRNSBlock Listing Six Monthly Return
8th May 20247:00 amRNSAppointment of New External Audit Firm
2nd May 20247:00 amRNSChange of Auditor
18th Apr 20247:00 amRNSTrading and Business Update
26th Feb 20247:00 amRNSAppointment of Nominated Adviser and Broker
1st Dec 20237:00 amRNSBlock Listing Six Monthly Return
16th Nov 20237:00 amRNSHalf Year Results
9th Nov 20231:50 pmRNSNOTICE OF HY RESULTS, RETAIL INVESTOR PRESENTATION
25th Oct 20239:32 amRNSPresenting at Proactive One2One Investor Forum
18th Oct 20237:00 amRNSTrading Update
19th Sep 20235:15 pmRNSResult of AGM
1st Aug 202311:33 amRNSUpdate regarding the PACCAR Matter
1st Aug 20237:00 amRNSGrant of Share Options
20th Jul 20237:00 amRNSGrant of Share Options
7th Jul 20237:00 amRNSDirector/PDMR Shareholding
5th Jul 20234:57 pmRNSPosting of Annual Report and Notice of AGM
29th Jun 20237:00 amRNSThird Year: Band 1 Insolvency Litigation Funding
22nd Jun 20237:00 amRNSAudited results for the year ended 31 March 2023
13th Jun 202310:30 amRNSInvestor Presentation via Investor Meet Company
13th Jun 20237:00 amRNSNotice of Results
1st Jun 20237:00 amRNSBlock Listing Six Monthly Return
22nd May 20237:00 amRNSRetail Investor Presentation at Mello2023
20th Apr 202312:30 pmRNSCORRECTION Further Trading Update
20th Apr 20237:00 amRNSFurther Trading Update
14th Mar 20231:49 pmRNSTrading Update
6th Feb 20237:00 amRNSHire of Former Government Counter-Fraud Expert
21st Dec 20229:11 amRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSBlock listing Six Monthly Return
10th Nov 20227:00 amRNSHalf Year Results
3rd Nov 20227:00 amRNSNotice of HY Results, Retail Investor Presentation
23rd Sep 20222:37 pmRNSUpdate on case
20th Sep 20222:00 pmRNSResult of AGM
9th Sep 20227:00 amRNSH1 Trading Update
1st Aug 202210:29 amRNSTotal Voting Rights
1st Aug 20227:00 amRNSGrant of Share Options and deferred bonus award
5th Jul 20225:04 pmRNSNotice of AGM
1st Jul 20227:00 amRNSBand 1 Ranking for Insolvency Litigation Funding
23rd Jun 20227:01 amRNSDirectorate Change
23rd Jun 20227:00 amRNSAudited results for the year ended 31 March 2022
16th Jun 20227:00 amRNSRetail Investor Presentation
15th Jun 20227:00 amRNSNotice of Results
1st Jun 20227:00 amRNSBlock Listing Six Monthly Return
3rd May 20227:00 amRNSTotal Voting Rights
26th Apr 20227:00 amRNSUpdate to recent Trading Statement & cash receipt
11th Apr 20227:00 amRNSTrading and business update
1st Mar 20227:00 amRNSTotal Voting Rights
6th Jan 20227:00 amRNSAppointment of Independent Non-Executive Director
4th Jan 20223:34 pmRNSTotal Voting Rights
3rd Dec 20217:00 amRNSGrant of Share Options
1st Dec 20217:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.